Posts tagged with 'outlook'
As Pharma Transforms, Drug Stocks Poised for ComebackRead the rest of this entry »
Big Pharma is poised for a financial comeback this year, even as both industry leaders and ambitious upstarts will navigate through choppy waters.
J.P. Morgan analyst Chris Schott wrote in mid-December that 2020 will be a recovery year for the stocks of major pharmaceutical companies. After a year in which the S&P 500 was up 25%, the S&P 500 Pharmaceuticals grew not even half that.
Schott basis his forecast on ...
Job Growth 'Slow, But Steady'Read the rest of this entry »
Solid, but slow job growth through the end of the year, is the prediction of the non-profit business group, The Conference Board.
The Board released its monthly Employment Trends Index Monday, which showed a rise of 1.68 from June's 109.3 reading. The Index now stands at 110.98.
“The Employment Trends Index increased in July but continues to hover around a flat trend since the summer of 2018,” said Gad Levanon, ...
The 'Next Big Thing' Is DeadRead the rest of this entry »
The “Next Big Thing” is dead, CompTIA declares in its annual IT outlook report. The trade association for the tech industry says the phenomenon of revolutionary products like smartphones is becoming less relevant “in a world defined not by ‘one big thing,’ but rather, the iterative fusion of technology building blocks coupled with a generous helping of people and process.”
That idea underlies the trends the organization believes will ...
Q1 Hiring Plans Are Strongest In YearsRead the rest of this entry »
The stock market may be seesawing, but employers are still bullish on hiring. Two recent surveys of hiring intention both pointed to strong plans by employers to add staff in the first quarter of this new year.
Manpower's long running Employment Outlook, based on a survey of 12,500 employers, shows 23% expect to add headcount between now and the end of March. Seasonally adjusted basis that comes out to ...
Biotech and Pharma: Outlook Is Overall PositiveRead the rest of this entry »
For the biotech and pharmaceutical industries, 2018 has proven to be a mixed bag, but with more overall positives than negatives.
In an article reviewing the year so far, and looking ahead to 2019, Peter Young president and managing director of the life science and chemicals investment banking firm Young & Partners, says drug approvals and development escalated and the emergence of new approaches in immuno-oncology, CRISPR, personalized medicine, and ...
Economic Forecast: Expect Volatility, Above Trend GrowthRead the rest of this entry »
Global growth is expected to be strong -- "above trend," is the exact language -- while in the U.S. "favorable financial conditions and stimulative fiscal policy should support economic momentum."
That's the assessment from J.P. Morgan's Global Fixed Income, Currency & Commodities Investment Quarterly meeting. The report earlier this month raised the "Above Trend Growth" scenario by 5 percentage points to 75% for the current quarter and possibly extending even ...
Banking's 10 Future Shock IssuesRead the rest of this entry »
2017 was a year of angst for the banking industry. Fintech, which begin its nascent ascendancy as a way to facilitate online transactions, has become both a partner and a challenger as cashless payments and virtual banking grows in popularity.
As American Banker said, "More fintech firms are being formed every day, promising to offer financial services faster and cheaper than banks, and the Silicon Valley giants are not far ...
Alternative Asset Outlook: '2018 Challenging for Many IM Firms'Read the rest of this entry »
2018 is the year the alternative asset sector may well go all-in for artificial intelligence and machine learning. That's likely to be one of the hottest trends for the industry, says Deloitte's 2018 Investment Management Outlook.
"70 percent of new hedge fund launches globally in 2018 will likely include investment processes that are supported by computer models, including AI and machine learning algorithms," says the report.
Existing funds are ...
Competition Will Put Even More Pricing Pressure On Pharma This YearRead the rest of this entry »
There's no shortage of predictions about what's ahead for the pharmaceutical and biotech sector in 2018. A Google search turns up dozens of articles and that's just in the last two weeks. And the range is broad -- from predictions of quicker FDA drug approvals to an aggressive entry into the field by tech companies, especially Google and Amazon and continued consolidation of the industry.
One of the trends most ...
2018 Hiring Outlook: More of the Same, Only TougherRead the rest of this entry »
If you thought it was tough finding the right people for your job last year, fasten your seat belt; by any measure, 2018 is going to be worse.
In just the last couple of months, a clutch of surveys and outlooks have published predicting hiring this year will be a lot like last year. The more optimistic among them, say there could be even more hiring. In this current quarter ...